Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.7573/dic.2020-4-5 http://scihub22266oqcxt.onion/10.7573/dic.2020-4-5 32373183!7192209!32373183     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Drugs+Context 2020 ; 9 (ä): ä Nephropedia Template TP {{tp|p=32373183|t=2020. Chloroquine and hydroxychloroquine in the context of COVID-19 |pdf=|usr=}}{{32373183}} gab.com Text Chloroquine and hydroxychloroquine in the context of COVID-19 JO: Drugs Context http://www.kidney.de/pget.php?&tw=1&pmid=32373183 #FOAvip Chloroquine and closely related structural analogs, employed initially for the treatment of malaria, are now gaining worldwide attention due to the rapidly spreading pandemic caused by severe acute respiratory syndrome-coronavirus-2, named coronavirus disease (COVID) of 2019 (COVID-19). Although much of this attention has a mechanistic basis, the hard efficacy data for chloroquine/hydroxychloroquine in the management of the clinical syndrome of COVID-19 have been limited thus far. This review aims to present the available in vitro and clinical data for the role of chloroquine/hydroxychloroquine in COVID-19 and attempts to put them into perspective, especially in relation to the different risks/benefits particular to each patient who may require treatment. Twit Text FOAVip Chloroquine and hydroxychloroquine in the context of COVID-19 ????Drugs Context http://www.kidney.de/pget.php?&tw=1&pmid=32373183 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32373183 #FOAvip English Wikipedia <ref>{{Cite pmid|32373183}}</ref> Chloroquine and hydroxychloroquine in the context of COVID-19 #MMPMID32373183 Shukla AM; Archibald LK; Wagle Shukla A; Mehta HJ; Cherabuddi K Drugs Context 2020[]; 9 (ä): ä PMID32373183show ga Chloroquine and closely related structural analogs, employed initially for the treatment of malaria, are now gaining worldwide attention due to the rapidly spreading pandemic caused by severe acute respiratory syndrome-coronavirus-2, named coronavirus disease (COVID) of 2019 (COVID-19). Although much of this attention has a mechanistic basis, the hard efficacy data for chloroquine/hydroxychloroquine in the management of the clinical syndrome of COVID-19 have been limited thus far. This review aims to present the available in vitro and clinical data for the role of chloroquine/hydroxychloroquine in COVID-19 and attempts to put them into perspective, especially in relation to the different risks/benefits particular to each patient who may require treatment. äChloroquine and hydroxychloroquine in the context of COVID-19 (epmc).pdf DeepDyve Pubget Overpricing